Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Biobanking of patient-derived cancer models for applied research and clinical application

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 27.01.20
Views: 77
Rating:

Dr Rita Lawlor - University of Verona, Verona, Italy

Dr Rita Lawlor speaks to ecancer at the BGICC 2020 conference in Cairo, Egypt about the use of biobanking and cancer models for applied cancer research.

She states that cancer research relies heavily on using tissue - which is a limited resource.

Dr Lawlor explains the use of patient-derived xenograft models as a method to obtain more tissue and the challenges that surround this.

 

Related videos

follow us

Biosimilar Medicines Core Principles and Communication


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation